Laird Superfood Reports First Quarter 2025 Financial Results
Re-affirms 2025 full year guidance.
During the quarter, our Gross Margin proved to be as resilient as expected despite the recent, historic run-up in commodities such as coffee prices and coconut milk powder. That strength translated to our bottom-line result as well, with an
First Quarter 2025 Highlights
-
Net Sales of$11.7 million compared to$9.9 million in the corresponding prior year period and$11.6 million in the fourth quarter of 2024. -
E-commerce sales increased by 6% year-over-year and contributed 53% of total
Net Sales , with significant improvements in media efficiency and strong performance on Amazon.com. -
Wholesale sales increased by 35% year-over-year and contributed 47% of total
Net Sales , primarily driven by distribution gains in grocery and club stores, partially offset by increased promotional trade spend. - Gross Margin was 41.9% compared to 40.0% in the corresponding prior year period, and 38.6% in the fourth quarter of 2024. Increased absorption of overhead related to inbound freight in the current quarter resulting from increased inventory purchases accounted for approximately 3.3 points of Gross Margin in Q1 2025. Gross Margin is expected to normalize for the balance of the year to achieve a high 30s percent for the full year in accordance with our guidance.
-
Net Loss was
$0.2 million , or$0.02 per diluted share, compared to Net Loss of$1.0 million , or$0.11 per diluted share, in the corresponding prior year period and Net Loss of$0.4 million , or$0.04 per diluted share, in the fourth quarter of 2024. The improvement was driven by Gross Margin expansion, as well as lower marketing, and general and administrative (G&A) costs. -
Adjusted earnings before interest, taxes, depreciation, amortization, stock-based compensation, and non-recurring items (“adjusted EBITDA”), which is a non-GAAP financial measure, was
$0.4 million , or$0.03 per diluted share, compared to($0.7) million , or ($0.08 ) per diluted share, in the corresponding prior year period and$0.2 million , or$0.01 per diluted share, in the fourth quarter of 2024. For more details on non-GAAP financial measures, refer to the information in the non-GAAP financial measures section of this press release.
Revenue Disaggregation
|
|
Three Months Ended |
||||||||||||||
|
|
2025 |
|
2024 |
||||||||||||
|
|
$ |
|
% of Total |
|
$ |
|
% of Total |
||||||||
Coffee creamers |
|
$ |
6,712,651 |
|
|
|
58 |
% |
|
$ |
5,570,321 |
|
|
|
56 |
% |
Coffee, tea, and hot chocolate products |
|
|
3,220,892 |
|
|
|
28 |
% |
|
|
2,175,265 |
|
|
|
22 |
% |
Hydration and beverage enhancing products |
|
|
2,106,179 |
|
|
|
18 |
% |
|
|
2,025,272 |
|
|
|
20 |
% |
Snacks and other food items |
|
|
1,430,729 |
|
|
|
12 |
% |
|
|
1,304,060 |
|
|
|
13 |
% |
Other |
|
|
71,682 |
|
|
|
1 |
% |
|
|
122,012 |
|
|
|
1 |
% |
Gross sales |
|
|
13,542,133 |
|
|
|
117 |
% |
|
|
11,196,930 |
|
|
|
112 |
% |
Shipping income |
|
|
122,274 |
|
|
|
1 |
% |
|
|
111,428 |
|
|
|
1 |
% |
Discounts and promotional activity |
|
|
(2,010,248 |
) |
|
|
(18 |
)% |
|
|
(1,399,420 |
) |
|
|
(13 |
)% |
Sales, net |
|
$ |
11,654,159 |
|
|
|
100 |
% |
|
$ |
9,908,938 |
|
|
|
100 |
% |
|
|
Three Months Ended |
||||||||||||||
|
|
2025 |
|
2024 |
||||||||||||
|
|
$ |
|
|
% of Total |
|
$ |
|
|
% of Total |
||||||
E-commerce |
|
$ |
6,213,116 |
|
|
|
53 |
% |
|
$ |
5,868,337 |
|
|
|
59 |
% |
Wholesale |
|
|
5,441,043 |
|
|
|
47 |
% |
|
|
4,040,601 |
|
|
|
41 |
% |
Sales, net |
|
$ |
11,654,159 |
|
|
|
100 |
% |
|
$ |
9,908,938 |
|
|
|
100 |
% |
Balance Sheet and Cash Flow Highlights
We had
Cash used in operating activities was
2025 Outlook
Management's strategy is to drive growth well in excess of the consumer goods and food industry averages:
-
Management re-affirms
Net Sales growth in the 20% to 25% range, driven by continued expansion across Wholesale accounts and further penetration of consumers on e-commerce platforms. - Gross Margin is expected to hold in the upper 30s, despite inflation in commodities and other cost pressures.
- Breakeven adjusted EBITDA.
-
Cash use of
$1 to$2 million for the full year to invest in inventory to support top line growth and to minimize out-of-stocks.
Conference Call and Webcast Details
We will host a conference call and webcast at
About
Forward-Looking Statements
This press release and the conference call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Laird Superfood’s anticipated cash runway, future financial performance, and growth. Such forward-looking statements may be identified by words such as "anticipates," "believes," "continues," "could," "estimates," "expects," "intends," "may," "outlook," "plans," "potential," predicts," "projects," "seeks," "should," "will," "would", or the antonyms of these terms or other comparable terminology. These forward-looking statements are based on Laird Superfood’s current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties, assumptions and changes in circumstances that may cause Laird Superfood’s actual results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement. We expressly disclaim any obligation to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
The risks and uncertainties referred to above include, but are not limited to: (1) the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, including on our supply chain, the demand for our products, and on overall economic conditions and consumer confidence and spending levels; (2) volatility regarding our revenue, expenses, including shipping expenses, and other operating results; (3) our ability to acquire new direct and wholesale customers and successfully retain existing customers; (4) our ability to attract and retain our suppliers, distributors and co-manufacturers, and effectively manage their costs and performance; (5) effects of real or perceived quality or health issues with our products or other issues that adversely affect our brand and reputation; (6) our ability to innovate on a timely and cost-effective basis, predict changes in consumer preferences and develop successful new products, or updates to existing products, and develop innovative marketing strategies; (7) adverse developments regarding prices and availability of raw materials and other inputs, a substantial amount of which come from a limited number of suppliers outside
|
||||||||
|
|
Three Months Ended |
||||||
|
|
|
||||||
|
|
2025 |
|
2024 |
||||
Sales, net |
|
$ |
11,654,159 |
|
|
$ |
9,908,938 |
|
Cost of goods sold |
|
|
(6,772,619 |
) |
|
|
(5,944,837 |
) |
Gross profit |
|
|
4,881,540 |
|
|
|
3,964,101 |
|
General and administrative |
|
|
|
|
|
|
|
|
Salaries, wages, and benefits |
|
|
1,158,155 |
|
|
|
922,407 |
|
Other general and administrative |
|
|
1,085,609 |
|
|
|
1,235,341 |
|
Total general and administrative expenses |
|
|
2,243,764 |
|
|
|
2,157,748 |
|
Sales and marketing |
|
|
|
|
|
|
|
|
Marketing and advertising |
|
|
1,731,036 |
|
|
|
2,053,258 |
|
Selling |
|
|
1,055,570 |
|
|
|
779,156 |
|
Related party marketing agreements |
|
|
69,189 |
|
|
|
62,501 |
|
Total sales and marketing expenses |
|
|
2,855,795 |
|
|
|
2,894,915 |
|
Total operating expenses |
|
|
5,099,559 |
|
|
|
5,052,663 |
|
Operating loss |
|
|
(218,019 |
) |
|
|
(1,088,562 |
) |
Other income |
|
|
74,448 |
|
|
|
110,997 |
|
Loss before income taxes |
|
|
(143,571 |
) |
|
|
(977,565 |
) |
Income tax expense |
|
|
(12,611 |
) |
|
|
(38,957 |
) |
Net loss |
|
$ |
(156,182 |
) |
|
$ |
(1,016,522 |
) |
Net loss per share: |
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(0.02 |
) |
|
$ |
(0.11 |
) |
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic and diluted |
|
|
10,345,495 |
|
|
|
9,401,605 |
|
|
||||||||
|
|
Three Months Ended
|
||||||
|
|
2025 |
|
2024 |
||||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(156,182 |
) |
|
$ |
(1,016,522 |
) |
Adjustments to reconcile net loss to net cash from operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
66,521 |
|
|
|
71,435 |
|
Stock-based compensation |
|
|
508,410 |
|
|
|
279,565 |
|
Provision for inventory obsolescence |
|
|
101,715 |
|
|
|
43,204 |
|
Other operating activities, net |
|
|
24,575 |
|
|
|
64,948 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(556,239 |
) |
|
|
(1,069,238 |
) |
Inventory |
|
|
(3,638,003 |
) |
|
|
646,231 |
|
Prepaid expenses and other current assets |
|
|
576,688 |
|
|
|
217,889 |
|
Operating lease liability |
|
|
(26,492 |
) |
|
|
(32,254 |
) |
Accounts payable |
|
|
1,032,391 |
|
|
|
70,901 |
|
Accrued expenses |
|
|
751,038 |
|
|
|
276,051 |
|
Related party liabilities |
|
|
40,834 |
|
|
|
25,479 |
|
Net cash from operating activities |
|
|
(1,274,744 |
) |
|
|
(422,311 |
) |
Cash flows from investing activities |
|
|
(72,214 |
) |
|
|
— |
|
Cash flows from financing activities |
|
|
(3,832 |
) |
|
|
4,791 |
|
Net change in cash and cash equivalents |
|
|
(1,350,790 |
) |
|
|
(417,520 |
) |
Cash, cash equivalents, and restricted cash, beginning of period |
|
|
8,514,152 |
|
|
|
7,706,806 |
|
Cash, cash equivalents, and restricted cash, end of period |
|
$ |
7,163,362 |
|
|
$ |
7,289,286 |
|
Supplemental disclosures of non-cash financing activities |
|
|
|
|
|
|
|
|
Prepaid expenses paid for with a short-term financing arrangement included in accrued expenses |
|
$ |
83,379 |
|
|
$ |
— |
|
Taxes withheld to cover net issuances of incentive stock awards included in accrued expenses |
|
$ |
214,489 |
|
|
$ |
— |
|
|
||||||||
|
|
As of |
||||||
|
|
|
|
|
||||
Assets |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash, cash equivalents, and restricted cash |
|
$ |
7,163,362 |
|
|
$ |
8,514,152 |
|
Accounts receivable, net |
|
|
2,317,635 |
|
|
|
1,762,911 |
|
Inventory |
|
|
9,511,964 |
|
|
|
5,975,676 |
|
Prepaid expenses and other current assets |
|
|
1,220,580 |
|
|
|
1,713,889 |
|
Total current assets |
|
|
20,213,541 |
|
|
|
17,966,628 |
|
Noncurrent assets |
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
109,195 |
|
|
|
58,447 |
|
Intangible assets, net |
|
|
851,068 |
|
|
|
896,123 |
|
Related party license agreements |
|
|
132,100 |
|
|
|
132,100 |
|
Right-of-use assets |
|
|
187,127 |
|
|
|
205,703 |
|
Total noncurrent assets |
|
|
1,279,490 |
|
|
|
1,292,373 |
|
Total assets |
|
$ |
21,493,031 |
|
|
$ |
19,259,001 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
3,170,151 |
|
|
$ |
2,137,760 |
|
Accrued expenses |
|
|
4,691,904 |
|
|
|
3,642,998 |
|
Related party liabilities |
|
|
75,781 |
|
|
|
34,947 |
|
Lease liabilities, current portion |
|
|
106,761 |
|
|
|
105,966 |
|
Total current liabilities |
|
|
8,044,597 |
|
|
|
5,921,671 |
|
Lease liabilities |
|
|
117,661 |
|
|
|
140,464 |
|
Total liabilities |
|
|
8,162,258 |
|
|
|
6,062,135 |
|
Stockholders’ equity |
|
|
|
|
|
|
|
|
Common stock, |
|
|
10,429 |
|
|
|
10,292 |
|
Additional paid-in capital |
|
|
121,594,836 |
|
|
|
121,304,884 |
|
Accumulated deficit |
|
|
(108,274,492 |
) |
|
|
(108,118,310 |
) |
Total stockholders’ equity |
|
|
13,330,773 |
|
|
|
13,196,866 |
|
Total liabilities and stockholders’ equity |
|
$ |
21,493,031 |
|
|
$ |
19,259,001 |
|
NON-GAAP FINANCIAL MEASURES
(unaudited)
In this press release, we report Adjusted EBITDA and Adjusted EBITDA per diluted share, which are financial measures not required by, or presented in accordance with, accounting principles generally accepted in
Management uses Adjusted EBITDA internally in analyzing the Company’s financial results to assess operational performance and to determine the Company’s future capital requirements. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared in accordance with GAAP. The Company believes that both management and investors benefit from referring to Adjusted EBITDA in assessing its performance and when planning, forecasting and analyzing future periods. The Company believes Adjusted EBITDA is useful to investors and others to understand and evaluate the Company’s operating results and it allows for a more meaningful comparison between the Company’s performance and that of competitors. Our use of Adjusted EBITDA has limitations as an analytical tool, and you should not consider this performance measure in isolation from or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that Adjusted EBITDA does not reflect, among other things: cash capital expenditures for assets underlying depreciation and amortization expense that may need to be replaced or for new capital expenditures; interest expense; income tax expense from continuing operations; our working capital requirements; the potentially dilutive impact of stock-based compensation; and the provision for income taxes. Other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
Because of these limitations, you should consider Adjusted EBITDA along with other financial performance measures, including
The following table presents a reconciliation of net income (loss), the most directly comparable financial measure stated in accordance with GAAP, to adjusted EBITDA, for each of the periods presented:
|
|
Three Months Ended
|
||||||
|
|
2025 |
|
2024 |
||||
Net loss |
|
$ |
(156,182 |
) |
|
$ |
(1,016,522 |
) |
Adjusted for: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
66,521 |
|
|
|
71,435 |
|
Stock-based compensation |
|
|
508,410 |
|
|
|
279,565 |
|
Income tax expense |
|
|
12,611 |
|
|
|
38,957 |
|
Interest expense and other (income) expense, net |
|
|
(74,448 |
) |
|
|
(110,997 |
) |
Product quality issue (a) |
|
|
— |
|
|
|
(11,195 |
) |
Adjusted EBITDA |
|
$ |
356,912 |
|
|
$ |
(748,757 |
) |
Net loss per share, diluted: |
|
$ |
(0.02 |
) |
|
$ |
(0.11 |
) |
Adjusted EBITDA per share, diluted: |
|
$ |
0.03 |
|
|
$ |
(0.08 |
) |
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic |
|
|
10,345,495 |
|
|
|
9,401,605 |
|
Dilutive securities |
|
|
1,514,828 |
|
|
|
— |
|
Weighted-average shares of common stock outstanding used in computing adjusted EBITDA per share of common stock, diluted |
|
|
11,860,323 |
|
|
|
9,401,605 |
|
(a) |
|
In |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250507695544/en/
Investor Relations Contact
investors@lairdsuperfood.com
Source: